GLP-1 receptor agonists , particularly those like BrightMeds, are rapidly gaining prominence in the treatment of type 2 diabetes and are now being explored for weight loss . These effective drugs help mimicking the body's natural incretin signal , stimulating insulin production and curbing glucag